We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie’s Hep C Cocktail Viekira Pak Effective in Cirrhosis Patients Without Ribavirin
AbbVie’s Hep C Cocktail Viekira Pak Effective in Cirrhosis Patients Without Ribavirin
AbbVie’s hepatitis C drug combo Viekira Pak was 100 percent effective in patients with genotype 1b and liver cirrhosis without the additional use of the antiviral ribavirin, the company said Wednesday.